We invite you to complete this short Consensus Survey in preparation for the MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, during EASL Congress in Barcelona, Spain.
- Scope: Microbiome-based mechanisms and biomarkers for improved patient stratification and prediction of therapeutic response in decompensated cirrhosis and acute-on-chronic liver failure (ACLF)
- Take the survey here: https://survey.alchemer.eu/s3/91085482/MICROB-PREDICT-Delphi-online-version
- Time to complete: 15-20 minutes
Your expertise in hepatology is highly valued and will contribute to building a structured, evidence-informed Delphi-style consensus in this rapidly evolving field.
Feel free to forward the survey to your colleagues as well. We are aiming to collect a worldwide vote and opinion on these topics.
Theme 1: Progression of decompensated cirrhosis and ACLF
Topic 1: Mechanisms of progression
Topic 2: Biomarkers of progression
Topic 3: Biomarkers of failure within the gut-liver axis
Theme 2: Mechanisms and biomarkers of therapeutic response
Topic 4: Albumin
Topic 5: Rifaximin
Topic 6: Terlipressin
Responses are fully anonymised and will be analysed in aggregate only.
Thank you in advance for taking a couple of minutes to complete the survey!
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825694. This survey reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains.
© MICROB-PREDICT 2026
